|
MAGI1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63369318073592E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.05022673785516E-12 |
| Normal-vs-Stage2 |
1.35630395803332E-11 |
| Normal-vs-Stage3 |
1.77635683940025E-14 |
| Normal-vs-Stage4 |
3.88578058618805E-15 |
| Stage1-vs-Stage2 |
1.384770E-01 |
| Stage1-vs-Stage3 |
1.061670E-02 |
| Stage1-vs-Stage4 |
4.22840000000591E-05 |
| Stage2-vs-Stage3 |
3.832800E-01 |
| Stage2-vs-Stage4 |
5.622200E-02 |
| Stage3-vs-Stage4 |
1.618960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.45958808875457E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
5.49330025911843E-10 |
| Caucasian-vs-AfricanAmerican |
9.589900E-02 |
| Caucasian-vs-Asian |
8.063600E-03 |
| AfricanAmerican-vs-Asian |
2.932000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62525548574877E-12 |
| Normal-vs-Female |
7.24449999989218E-09 |
| Male-vs-Female |
1.932240E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.88219999586181E-08 |
| Normal-vs-Extreme_Weight |
1.68542957368345E-12 |
| Normal-vs-Obese |
1.66422431391311E-13 |
| Normal-vs-Extreme_Obese |
1.29989999986257E-07 |
| Normal_Weight-vs-Extreme_Weight |
3.420800E-01 |
| Normal_Weight-vs-Obese |
9.759800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.424200E-01 |
| Extreme_Weight-vs-Obese |
2.022400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.192600E-01 |
| Obese-vs-Extreme_Obese |
5.183600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.01685368195604E-12 |
| Normal-vs-Age(41-60Yrs) |
1.85629289717326E-13 |
| Normal-vs-Age(61-80Yrs) |
1.80877535171931E-12 |
| Normal-vs-Age(81-100Yrs) |
5.18529996718087E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.293800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.321800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.904800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.256200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.159700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.189180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.71562763995325E-12 |
| Normal-VS-KIRP CIMP |
1.9080000024374E-08 |
| Normal-VS-Unclassified PRCC |
6.15159999606263E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.085400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.642000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.639800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.108000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.593150E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.067190E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6565637750432E-12 |
| Normal-vs-N1 |
1.14463993838854E-13 |
| Normal-vs-N2 |
1.768910E-04 |
| N0-vs-N1 |
7.323800E-01 |
| N0-vs-N2 |
8.478600E-01 |
| N1-vs-N2 |
9.785000E-01 |
|
|
